Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Cipla
Fish and Richardson
Harvard Business School
Merck
Dow
Johnson and Johnson
US Department of Justice
Argus Health
Boehringer Ingelheim

Generated: August 23, 2017

DrugPatentWatch Database Preview

Aurobindo Company Profile

« Back to Dashboard

What is the competitive landscape for AUROBINDO, and what generic and branded alternatives to AUROBINDO drugs are available?

AUROBINDO has two hundred and eighty-eight approved drugs.

There are thirty-five tentative approvals on AUROBINDO drugs.

Summary for Applicant: Aurobindo

Patents:0
Tradenames:223
Ingredients:200
NDAs:288
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
AMOXICILLIN AND CLAVULANATE POTASSIUM
amoxicillin; clavulanate potassium
FOR SUSPENSION;ORAL201090-001Dec 20, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
ATOMOXETINE HYDROCHLORIDE
atomoxetine hydrochloride
CAPSULE;ORAL079016-004May 30, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
IRBESARTAN
irbesartan
TABLET;ORAL203081-003Sep 27, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma Ltd
RISEDRONATE SODIUM
risedronate sodium
TABLET;ORAL200296-002Nov 30, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurobindo Pharma
CEFOTAXIME SODIUM
cefotaxime sodium
INJECTABLE;INJECTION065517-003Nov 6, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for AUROBINDO drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazole
Delayed-release Tablets20 mg
OMEPRAZOLE
6/3/2015

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Chinese Patent Office
Cipla
Dow
Cerilliant
Express Scripts
McKesson
Baxter
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot